| Mrs Keri Yvonne Deyling, LISW | |
|
18 N Forge St, Akron, OH 44304-1317 | |
| (330) 762-0591 | |
| (330) 762-2242 |
| Full Name | Mrs Keri Yvonne Deyling |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 18 N Forge St, Akron, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033535240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | I1440096 (Ohio) | Primary |
| Entity Name | Coleman Professional Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982637633 PECOS PAC ID: 2769474618 Enrollment ID: O20040331001085 |
News Archive
In a two-part series in his Slate blog "The Reckoning," author Michael Moran examines the "silo" effect of Western aid to improve health in Africa, writing in the first part, "Charities know that raising money for exotic disease eradication in the West is a good deal easier than, say, funding upgrades to substandard cardiac facilities.
"We are surprised and saddened that Innova has persisted in selling their infringing system"
Henry Schein Animal Health, the leading companion animal health distributor in the United States, and the U.S. animal health business of Henry Schein, Inc., announced today that it has launched a new iPad® online ordering application to help veterinary practitioners manage their product purchases.
AliveCor, Inc. announced today it has received CE Mark clearance for its automated analysis process (algorithm) to detect atrial fibrillation (AF), the most common heart rhythm disturbance and a leading cause of stroke. The latest version of the AliveECG app for users in the United Kingdom and Ireland now provides patients with real-time AF detection in electrocardiogram (ECG) recordings using the AliveCor Heart Monitor.
Repligen Corporation today announced preliminary financial results for fiscal year 2010 which ended March 31, 2010. Total revenue for the year is expected to be $21.0 million, including $10.3 million of bioprocessing product revenue and $10.7 million of royalty and other revenue. Research and development expenses are expected to be between $13.8-$14.2 million and selling, general and administrative expenses between $6.8-$7.2 million.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Keri Yvonne Deyling, LISW 87 N Canton Rd, Akron, OH 44305-3838 Ph: (330) 794-4254 | Mrs Keri Yvonne Deyling, LISW 18 N Forge St, Akron, OH 44304-1317 Ph: (330) 762-0591 |
News Archive
In a two-part series in his Slate blog "The Reckoning," author Michael Moran examines the "silo" effect of Western aid to improve health in Africa, writing in the first part, "Charities know that raising money for exotic disease eradication in the West is a good deal easier than, say, funding upgrades to substandard cardiac facilities.
"We are surprised and saddened that Innova has persisted in selling their infringing system"
Henry Schein Animal Health, the leading companion animal health distributor in the United States, and the U.S. animal health business of Henry Schein, Inc., announced today that it has launched a new iPad® online ordering application to help veterinary practitioners manage their product purchases.
AliveCor, Inc. announced today it has received CE Mark clearance for its automated analysis process (algorithm) to detect atrial fibrillation (AF), the most common heart rhythm disturbance and a leading cause of stroke. The latest version of the AliveECG app for users in the United Kingdom and Ireland now provides patients with real-time AF detection in electrocardiogram (ECG) recordings using the AliveCor Heart Monitor.
Repligen Corporation today announced preliminary financial results for fiscal year 2010 which ended March 31, 2010. Total revenue for the year is expected to be $21.0 million, including $10.3 million of bioprocessing product revenue and $10.7 million of royalty and other revenue. Research and development expenses are expected to be between $13.8-$14.2 million and selling, general and administrative expenses between $6.8-$7.2 million.
› Verified 9 days ago
Carol Ann Downs, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 312 Locust St, Akron, OH 44302 Phone: 330-762-0591 Fax: 330-762-2242 | |
Mrs. Tessa Claire Basco, LISW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: Summa Family Medicine Center, 55 Arch St Suite 3a, Akron, OH 44304 Phone: 330-375-3584 | |
Stephanie Macdonald, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 340 S Broadway St, Akron, OH 44308 Phone: 330-253-3100 Fax: 330-253-5466 | |
Mr. Robert Terry, MSSA, LISW-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 702 E Market St, Akron, OH 44305 Phone: 330-315-3756 | |
Ms. Lisa J. Zinn, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 312 Locust St, Akron, OH 44302 Phone: 330-762-0591 Fax: 330-762-2242 | |
Ms. Ashley Michel Halasa, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1016 Ivor Ave, Akron, OH 44314 Phone: 330-388-0219 |